BDBM72385 2-azanylidene-3-(2,3-dimethylphenyl)-1,3-thiazolidin-4-one::3-(2,3-dimethylphenyl)-2-imino-1,3-thiazolidin-4-one::3-(2,3-dimethylphenyl)-2-imino-4-thiazolidinone::3-(2,3-dimethylphenyl)-2-imino-thiazolidin-4-one::MLS000680549::SMR000268735::cid_613215

SMILES O=C1c2c(ccc(C(F)(F)F)c2F)N2CN1c1ccc(=O)[nH]c1NCCCc1c2ccc(F)c1F

InChI Key InChIKey=KCXPQKDQAVQMLN-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72385   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72385BDBM72385(1,8,9-Trifluoro-2-(trifluoromethyl)-10,11,12,13-te...)
Affinity DataIC50: 25.1nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent